Related content

Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and Celecoxib

By Brenner S.S.   Herrlinger C.   Dilger K.   Murdter T.E.   Hofmann U.   Marx C.   Klotz U.  

Clinical Pharmacokinetics, Vol. 42, Iss. 3, 2003-01 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity

By Kealey Carmel   Chen Zhen   Christie Jason   Thorn Caroline F   Whitehead Alexander S   Price Maureen   Samaha Frederick F   Kimmel Stephen E  

Pharmacogenomics, Vol. 8, Iss. 3, 2007-03 ,pp. : 217-225

Future Medicine

Access to resources Recommend Favorite

Genetic polymorphism of cytochrome P₄₅₀ 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

By Lee Ai-Young   Kim Min-Jung   Chey Won-Young   Choi Jun   Kim Byung-Gun  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 155-159

Springer Publishing Company

Access to resources Recommend Favorite

Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance

By  

Current Drug Metabolism, Vol. 10, Iss. 7, 2009-09 ,pp. : 781-834

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

By Desta Z.   Zhao X.   Shin J-G.   Flockhart D.A.  

Clinical Pharmacokinetics, Vol. 41, Iss. 12, 2002-01 ,pp. : 913-958

Adis International

Access to resources Recommend Favorite